Company / Working Capital per Share
MoonLake Immunotherapeutics Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.84
FY2025
5-year range
-$1.46 / $10.26
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#96 of 210
Health Care
What the data says
At $5.84, MoonLake Immunotherapeutics's working capital per share ranks #96 of 210 in the Health Care sector. Declined from $10.26 to $5.84 over the past 2 years.
Based on SEC 10-K filings.
5.84 in FY2025 with a 5-year CAGR of +89.4%.
Declined from $10.26 to $5.84 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +35.5%
- 5-Year CAGR
- +89.4%
- 10-Year CAGR
- -
Sector benchmark
#96 of 210 in Health CareTop 46% of 210This company $5.84 Sector average $146.86
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 18.8% year-over-year.
- Ranks #96 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.84 | -18.8% |
| FY2024 | $7.19 | -30.0% |
| FY2023 | $10.26 | +337.7% |
| FY2022 | $2.34 | +260.6% |
| FY2021 | -$1.46 | -709.3% |
| FY2020 | $0.24 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026